Successful treatment of sarcoidosis with leflunomide [7]

Rheumatology

Volumn 42, Issue 5, 2003, Pages 700-702

  Majithia, V ^a   Sanders, S ^a   Harisdangkul, V ^a   Wilson, J G ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOTOXIC AGENT; HYDROXYCHLOROQUINE; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; METHOTREXATE; PENTOXIFYLLINE; PREDNISONE; ISOXAZOLE DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; BIOPSY TECHNIQUE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; COUGHING; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE ACTIVITY; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; IMMUNOMODULATION; LABORATORY TEST; LETTER; MALE; PRIORITY JOURNAL; RASH; SARCOIDOSIS; SINUSITIS; SKIN MANIFESTATION;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; MALE; SARCOIDOSIS;

EID: 0043280975     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keg156     Document Type: Letter

References (9)

1. Baughman RP, Teirstein AS, Judson MA et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001;164:1885-9.
2. Baughman RP, Winget DB, Lower EE. Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. Sarcoidosis Vasc Diffuse Lung Dis 2000;17:60-6.
3. Baughman RP, Lower EE, Lynch JP III. Treatment modalities for sarcoidosis. Clin Pulm Med 1994;1:223-9.
4. Baltzan M, Mehta S, Kirkham TH, Cosio MG. Randomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis. Am J Respir Crit Care Med 1999;160:192-7.
5. Wyser CP, van Schalkwyk E, Alheit B et al. Treatment of progressive pulmonary sarcoidosis with cyclosporin A. Am J Respir Crit Care Med 1997;156:1371-6.
6. Zabel P, Entzian P, Dalhoff K, Schlaak M. Pentoxifylline in treatment of sarcoidosis. Am J Respir Crit Care Med 1997; 155:1665-9.
7. Ruckemann K, Fairbanks LD, Carrey EA et al. Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans. J Biol Chem 1998;273:21682-91.
8. Hermann ML, Schleyerback R, Kirschbaum BJ. Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases, Immunopharmacology 2000;47:273-89.
9. Metzler C, Low-Friedrich I, Reinhold-Keller E et al. Leflunomide, a new and promising agent in maintenance of remission in Wegener's granulomatosis [abstract]. Clin Exp Immunol 1998; 112(Suppl. 1):56.